Optimized scheduling in real-time environments with column generation

Im Bereich sicherheitsrelevanter eingebetteter Systeme stellt sich der Designprozess von Anwendungen als sehr komplex dar. Entsprechend einer gegebenen Hardwarearchitektur lassen sich Steuergeräte aufrüsten, um alle bestehenden Prozesse und Signale pünktlich auszuführen. Die zeitlichen Anforderungen sind strikt und müssen in jeder periodischen Wiederkehr der Prozesse erfüllt sein, da die Sicherstellung der parallelen Ausführung von größter Bedeutung ist. Existierende Ansätze können schnell Designalternativen berechnen, aber sie gewährleisten nicht, dass die Kosten für die nötigen Hardwareänderungen minimal sind. Wir stellen einen Ansatz vor, der kostenminimale Lösungen für das Problem berechnet, die alle zeitlichen Bedingungen erfüllen. Unser Algorithmus verwendet Lineare Programmierung mit Spaltengenerierung, eingebettet in eine Baumstruktur, um untere und obere Schranken während des Optimierungsprozesses bereitzustellen. Die komplexen Randbedingungen zur Gewährleistung der periodischen Ausführung verlagern sich durch eine Zerlegung des Hauptproblems in unabhängige Unterprobleme, die als ganzzahlige lineare Programme formuliert sind. Sowohl die Analysen zur Prozessausführung als auch die Methoden zur Signalübertragung werden untersucht und linearisierte Darstellungen angegeben. Des Weiteren präsentieren wir eine neue Formulierung für die Ausführung mit fixierten Prioritäten, die zusätzlich Prozessantwortzeiten im schlimmsten anzunehmenden Fall berechnet, welche für Szenarien nötig sind, in denen zeitliche Bedingungen an Teilmengen von Prozessen und Signalen gegeben sind. Wir weisen die Anwendbarkeit unserer Methoden durch die Analyse von Instanzen nach, welche Prozessstrukturen aus realen Anwendungen enthalten. Unsere Ergebnisse zeigen, dass untere Schranken schnell berechnet werden können, um die Optimalität von heuristischen Lösungen zu beweisen. Wenn wir optimale Lösungen mit Antwortzeiten liefern, stellt sich unsere neue Formulierung in der Laufzeitanalyse vorteilhaft gegenüber anderen Ansätzen dar. Die besten Resultate werden mit einem hybriden Ansatz erzielt, der heuristische Startlösungen, eine Vorverarbeitung und eine heuristische mit einer kurzen nachfolgenden exakten Berechnungsphase verbindet.

Valutazione delle funzioni obiettivo nell'operating theatre scheduling

il ruolo della tesi è stato di valorizzare attraverso la valutazione di un peso l'urgenza e la necessità di cure dei pazienti processati da un modello di ottimizzazione. Essa si inserisce all'interno di un progetto di creazione di tale modello per la schedulazione di interventi in un reparto chirurgico di un generico ospedale.si è fatto uso del software ibm opl optimization suite.

Scheduling di applicazioni periodiche con durata variabile

In questa tesi presentiamo una strategia, e la relativa implementazione, per il problema dell’allocazione e schedulazione, su risorse unarie, di applicazioni multi-task periodiche, composte da attività che interagiscono fra loro e la cui durata è incerta. Lo scopo che ci si propone di raggiungere, è l’implementazione di una strategia di allocazione schedulazione che garantisca robustezza ed efficienza, in quei contesti in cui la conoscenza a priori è limitata e in cui le applicazioni si ripetono indefinitamente nel tempo. Per raggiungere questo scopo, sarà usato un approccio ibrido fra statico e dinamico. Staticamente è generata una soluzione del problema, sfruttando la programmazione a vincoli, in cui le durate delle attività sono arbitrariamente fissate. Questa soluzione, non rappresenta la soluzione del nostro problema, ma è utilizzata per generare un ordinamento delle attività, che compongono le applicazioni periodiche. Dinamicamente, sfruttando l’ordinamento ottenuto, è effettuata l’allocazione e la schedulazione effettiva delle applicazioni periodiche, considerando durate variabili per le attività. L’efficienza ottenuta applicando il nostro approccio è valutata effettuando test su una vasta gamma di istanze, sia industriali, sia sintetiche appositamente generate. I risultati sono confrontati con quelli ottenuti, per le stesse istanze, applicando un approccio puramente statico. Come si vedrà, in alcuni casi, è possibile anche quadruplicale la velocità di completamento delle applicazioni trattate.

Distributed allocation and scheduling of applications on HPC platforms

High Performance Computing e una tecnologia usata dai cluster computazionali per creare sistemi di elaborazione che sono in grado di fornire servizi molto piu potenti rispetto ai computer tradizionali. Di conseguenza la tecnologia HPC e diventata un fattore determinante nella competizione industriale e nella ricerca. I sistemi HPC continuano a crescere in termini di nodi e core. Le previsioni indicano che il numero dei nodi arrivera a un milione a breve. Questo tipo di architettura presenta anche dei costi molto alti in termini del consumo delle risorse, che diventano insostenibili per il mercato industriale. Un scheduler centralizzato non e in grado di gestire un numero di risorse cosi alto, mantenendo un tempo di risposta ragionevole. In questa tesi viene presentato un modello di scheduling distribuito che si basa sulla programmazione a vincoli e che modella il problema dello scheduling grazie a una serie di vincoli temporali e vincoli sulle risorse che devono essere soddisfatti. Lo scheduler cerca di ottimizzare le performance delle risorse e tende ad avvicinarsi a un profilo di consumo desiderato, considerato ottimale. Vengono analizzati vari modelli diversi e ognuno di questi viene testato in vari ambienti.

[CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (Chinese version)]

Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs) is not optimal. Without transparent reporting, readers cannot judge the reliability and validity of trial findings nor extract information for systematic reviews. Recent methodological analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such systematic error is seriously damaging to RCTs, which are considered the gold standard for evaluating interventions because of their ability to minimise or avoid bias. A group of scientists and editors developed the CONSORT (Consolidated Standards of Reporting Trials) statement to improve the quality of reporting of RCTs. It was first published in 1996 and updated in 2001. The statement consists of a checklist and flow diagram that authors can use for reporting an RCT. Many leading medical journals and major international editorial groups have endorsed the CONSORT statement. The statement facilitates critical appraisal and interpretation of RCTs. During the 2001 CONSORT revision, it became clear that explanation and elaboration of the principles underlying the CONSORT statement would help investigators and others to write or appraise trial reports. A CONSORT explanation and elaboration article was published in 2001 alongside the 2001 version of the CONSORT statement. After an expert meeting in January 2007, the CONSORT statement has been further revised and is published as the CONSORT 2010 Statement. This update improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias. This explanatory and elaboration document-intended to enhance the use, understanding, and dissemination of the CONSORT statement-has also been extensively revised. It presents the meaning and rationale for each new and updated checklist item providing examples of good reporting and, where possible, references to relevant empirical studies. Several examples of flow diagrams are included. The CONSORT 2010 Statement, this revised explanatory and elaboration document, and the associated website (www.consort-statement.org) should be helpful resources to improve reporting of randomised trials.

CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials

Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs) is not optimal. Without transparent reporting, readers cannot judge the reliability and validity of trial findings nor extract information for systematic reviews. Recent methodological analyses indicate that inadequate reporting and design are associated with biased estimates of treatment effects. Such systematic error is seriously damaging to RCTs, which are considered the gold standard for evaluating interventions because of their ability to minimise or avoid bias. A group of scientists and editors developed the CONSORT (Consolidated Standards of Reporting Trials) statement to improve the quality of reporting of RCTs. It was first published in 1996 and updated in 2001. The statement consists of a checklist and flow diagram that authors can use for reporting an RCT. Many leading medical journals and major international editorial groups have endorsed the CONSORT statement. The statement facilitates critical appraisal and interpretation of RCTs. During the 2001 CONSORT revision, it became clear that explanation and elaboration of the principles underlying the CONSORT statement would help investigators and others to write or appraise trial reports. A CONSORT explanation and elaboration article was published in 2001 alongside the 2001 version of the CONSORT statement. After an expert meeting in January 2007, the CONSORT statement has been further revised and is published as the CONSORT 2010 Statement. This update improves the wording and clarity of the previous checklist and incorporates recommendations related to topics that have only recently received recognition, such as selective outcome reporting bias. This explanatory and elaboration document-intended to enhance the use, understanding, and dissemination of the CONSORT statement-has also been extensively revised. It presents the meaning and rationale for each new and updated checklist item providing examples of good reporting and, where possible, references to relevant empirical studies. Several examples of flow diagrams are included. The CONSORT 2010 Statement, this revised explanatory and elaboration document, and the associated website (www.consort-statement.org) should be helpful resources to improve reporting of randomised trials.

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

Patients with ischaemic stroke or transient ischaemic attack (TIA) are at high risk of recurrent stroke or other cardiovascular events. We compared the selective thromboxane-prostaglandin receptor antagonist terutroban with aspirin in the prevention of cerebral and cardiovascular ischaemic events in patients with a recent non-cardioembolic cerebral ischaemic event.